Texas Brain Economy Summit 2026: Catalyzing a new wave of innovation and economic growth June 4, 2026 • 1:35 p.m. by Margaret Battistelli Gardner and Leslie Sanderson The high-impact summit will convene more than 600 senior executives, innovators, researchers, investors, entrepreneurs, and policymakers to explore one of the most significant opportunities of our time: building a thriving global brain economy. UTMB research advances Bundibugyo Ebola vaccine data June 4, 2026 • 8:00 a.m. by Margaret Battistelli Gardner Early studies show a Bundibugyo Ebola vaccine candidate protected nonhuman primates, supporting preparedness as the Democratic Republic of the Congo and neighboring countries work to contain cases. New research examines how mild brain injury sparks early immune response June 3, 2026 • 12:38 p.m. by Leslie Sanderson The link between early neuronal damage and the brain’s immune response is poorly understood, but the significance of concussive injury has become a topic of public interest over the last few years, especially in the context of sports injuries. In this study, UTMB researchers were interested in the type of concussion that occurs when impact does not penetrate the brain but causes it to move inside the skull, resulting in injury. UTMB strengthens frontline preparedness for special pathogens June 2, 2026 • 4:32 p.m. by Margaret Battistelli Gardner From advanced biocontainment care to regional training, UTMB is strengthening readiness to protect patients, healthcare workers, and communities from emerging infectious threats. UTMB researchers identify SARS-CoV-2 proteins that let COVID-19 outsmart the immune system May 29, 2026 • 5:00 a.m. by Margaret Battistelli Gardner UTMB scientists identified two SARS-CoV-2 proteins that suppress early immune defenses, advancing understanding of COVID-19 infection and informing future antiviral and vaccine strategies. Turning back the clock on the microbiome is key to preventing liver cancer and aging, study finds May 27, 2026 • 3:53 p.m. by Katherine Adams Researchers are increasingly linking age-related changes in the intestinal microbiome to chronic inflammation, liver dysfunction, and higher cancer risk, suggesting gut health plays a key role in long-term disease prevention. UTMB recognized for role in advancing promising Crimean-Congo hemorrhagic fever vaccine May 21, 2026 • 3:56 p.m. by Margaret Battistelli Gardner The university’s infectious disease researchers helped generate preclinical data that moved the vaccine into FDA cleared Phase 1 trials, earning national recognition for their role in a multiagency effort to counter a growing global health threat. Researchers double success rate of initial depression treatment with MRI-guided approach May 20, 2026 • 8:08 a.m. by Leslie Sanderson A collaborative team of researchers from The University of Texas Medical Branch (UTMB) and Stanford University has published an article in Nature Mental Health showing how MRI can guide treatment decisions for patients with depression. The precision medicine approach doubles the success rate of initial treatment. UTMB researchers identify enzyme that prevents chromosome breaks during DNA copying May 15, 2026 • 9:00 a.m. by Staff A new UTMB study reveals how the enzyme ATR prevents chromosomes from breaking when DNA replication hits damaged roadblocks. UTMB students delve into science policy and advocacy at AAAS workshop April 17, 2026 • 8:11 a.m. by Leslie Sanderson Four graduate students from The University of Texas Medical Branch (UTMB) traveled to Washington, D.C., to participate in the American Association for the Advancement of Science (AAAS) Catalyzing Advocacy in Science and Engineering (CASE) Workshop. Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
Texas Brain Economy Summit 2026: Catalyzing a new wave of innovation and economic growth June 4, 2026 • 1:35 p.m. by Margaret Battistelli Gardner and Leslie Sanderson The high-impact summit will convene more than 600 senior executives, innovators, researchers, investors, entrepreneurs, and policymakers to explore one of the most significant opportunities of our time: building a thriving global brain economy.
UTMB research advances Bundibugyo Ebola vaccine data June 4, 2026 • 8:00 a.m. by Margaret Battistelli Gardner Early studies show a Bundibugyo Ebola vaccine candidate protected nonhuman primates, supporting preparedness as the Democratic Republic of the Congo and neighboring countries work to contain cases.
New research examines how mild brain injury sparks early immune response June 3, 2026 • 12:38 p.m. by Leslie Sanderson The link between early neuronal damage and the brain’s immune response is poorly understood, but the significance of concussive injury has become a topic of public interest over the last few years, especially in the context of sports injuries. In this study, UTMB researchers were interested in the type of concussion that occurs when impact does not penetrate the brain but causes it to move inside the skull, resulting in injury.
UTMB strengthens frontline preparedness for special pathogens June 2, 2026 • 4:32 p.m. by Margaret Battistelli Gardner From advanced biocontainment care to regional training, UTMB is strengthening readiness to protect patients, healthcare workers, and communities from emerging infectious threats.
UTMB researchers identify SARS-CoV-2 proteins that let COVID-19 outsmart the immune system May 29, 2026 • 5:00 a.m. by Margaret Battistelli Gardner UTMB scientists identified two SARS-CoV-2 proteins that suppress early immune defenses, advancing understanding of COVID-19 infection and informing future antiviral and vaccine strategies.
Turning back the clock on the microbiome is key to preventing liver cancer and aging, study finds May 27, 2026 • 3:53 p.m. by Katherine Adams Researchers are increasingly linking age-related changes in the intestinal microbiome to chronic inflammation, liver dysfunction, and higher cancer risk, suggesting gut health plays a key role in long-term disease prevention.
UTMB recognized for role in advancing promising Crimean-Congo hemorrhagic fever vaccine May 21, 2026 • 3:56 p.m. by Margaret Battistelli Gardner The university’s infectious disease researchers helped generate preclinical data that moved the vaccine into FDA cleared Phase 1 trials, earning national recognition for their role in a multiagency effort to counter a growing global health threat.
Researchers double success rate of initial depression treatment with MRI-guided approach May 20, 2026 • 8:08 a.m. by Leslie Sanderson A collaborative team of researchers from The University of Texas Medical Branch (UTMB) and Stanford University has published an article in Nature Mental Health showing how MRI can guide treatment decisions for patients with depression. The precision medicine approach doubles the success rate of initial treatment.
UTMB researchers identify enzyme that prevents chromosome breaks during DNA copying May 15, 2026 • 9:00 a.m. by Staff A new UTMB study reveals how the enzyme ATR prevents chromosomes from breaking when DNA replication hits damaged roadblocks.
UTMB students delve into science policy and advocacy at AAAS workshop April 17, 2026 • 8:11 a.m. by Leslie Sanderson Four graduate students from The University of Texas Medical Branch (UTMB) traveled to Washington, D.C., to participate in the American Association for the Advancement of Science (AAAS) Catalyzing Advocacy in Science and Engineering (CASE) Workshop.